NFKB1 and osteosarcoma: In addition, TNF‐α and ILs are transcriptionally controlled by NF‐kB and C3 signaling12, 13; therefore, searching the upstream key factors to regulate the inflammatory response may be a vital step in the treatment of osteosarcoma.